Visx/Summit Enter FTC Consent Decrees On Pillar Point Partners Venture
This article was originally published in The Gray Sheet
Executive Summary
Visx and Summit Technology have entered separate consent decree settlements with the Federal Trade Commission regarding their Pillar Point Partners joint venture, the two ophthalmic laser manufacturers announced July 8.
You may also be interested in...
Visx
Ophthalmic laser firm will pay about $37.8 mil. to settle antitrust class action suits relating to its Pillar Point joint venture with competitor Summit Autonomous (1"The Gray Sheet" July 13, 1998, p. 15). Alcon Labs' Summit unit also has settled under separate arrangements. Pillar Point was deemed anti-competitive by FTC, which alleged the firms were preventing competitors from entering the laser vision correction market by failing to license patents
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.